Synthesis of Hemiprotonic Phenanthroline–Phenanthroline + Compounds with both Antitumor and Antimicrobial Activity

Zizhen Zhao,Xiaorong Li,Zhihong Cui,Tingting Tong,Yingying Zhang,Yuping Zhang,Xiaoxi Yang,Rajendiran Keerthiga,Chen Fu,Ailing Fu
DOI: https://doi.org/10.1021/acs.jmedchem.1c01982
IF: 8.039
2022-01-24
Journal of Medicinal Chemistry
Abstract:Currently, cancer patients with microbial infection are a severe challenge in clinical treatment. To address the problem, we synthesized hemiprotonic compounds based on the unique structure of hemiprotonic nucleotide base pairs in a DNA i-motif. These compounds were produced from phenanthroline (ph) dimerization with phenanthroline as a proton receptor and ammonium as a donor. The biological activity shows that the compounds have a selective antitumor effect through inducing cell apoptosis. The molecular mechanism could be related to specific inhibition of transcription factor <i>PLAGL2</i> of tumor cells, assessed by transcriptomic analysis. Moreover, results show that the hemiprotonic ph-ph<sup>+</sup> has broad-spectrum antibacterial and antifungal activities, and drug-resistant bacteria, including methicillin-resistant <i>Staphylococcus aureus</i>, are sensitive to the compound. In animal models of liver cancer with fungal infection, the ph-ph<sup>+</sup> retards proliferation of hepatoma cells in tumor-bearing mice and remedies pneumonia and encephalitis caused by <i>Cryptococcus neoformans</i>. The study provides a novel therapeutic candidate for cancer patients accompanied by infection.
chemistry, medicinal
What problem does this paper attempt to address?